Zobrazeno 1 - 10
of 37
pro vyhledávání: '"R. Nickander"'
Publikováno v:
Annual Review of Pharmacology and Toxicology. 19:469-490
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c1594347042978ce001efb011aee51
https://doi.org/10.1146/annurev.pa.19.040179.002345
https://doi.org/10.1146/annurev.pa.19.040179.002345
Autor:
D M, Zimmerman, S E, Smits, M D, Hynes, B E, Cantrell, J D, Leander, L G, Mendelsohn, R, Nickander
Publikováno v:
Drug and Alcohol Dependence. 14:381-401
Picenadol is a unique opioid mixed agonist-antagonist analgesic currently under clinical evaluation. Structurally, picenadol is a 4-phenylpiperidine derivative and a racemic mixture whose mixed agonist-antagonist properties are a consequence of the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7878c00653cbc0145f8d8c67db0d4aaa
https://doi.org/10.1016/0376-8716(85)90069-9
https://doi.org/10.1016/0376-8716(85)90069-9
Publikováno v:
Toxicology and Applied Pharmacology. 25:398-409
Tobramycin, an aminoglycoside antibiotic, has been administered to mice, rats, cats and dogs for toxicologic evaluation. The sc LD50 values in mice and rats were 441 and 969 mg/kg, respectively. Deaths were preceded by CNS depression and occurred wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156d20574e320fae822e3f181cb2bca9
https://doi.org/10.1016/0041-008x(73)90313-x
https://doi.org/10.1016/0041-008x(73)90313-x
Publikováno v:
NIDA research monograph. 41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2690cd7331556414e027b5ff4ac56a7f
https://pubmed.ncbi.nlm.nih.gov/6289111
https://pubmed.ncbi.nlm.nih.gov/6289111
Autor:
R. Nickander, D. N. Benslay
Publikováno v:
Agents and actions. 12(3)
Benoxaprofen, a new nonsteroidal anti-inflammatory agent recently marketed as an an antirheumatic drug, has been reported to suppress leucocyte migration into inflammatory sites, possibly by its reported inhibition of leukotriene synthesis. Benoxapro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9853dbdcd1089dda7330cd87fed7b9e0
https://pubmed.ncbi.nlm.nih.gov/7136958
https://pubmed.ncbi.nlm.nih.gov/7136958
Publikováno v:
NIDA research monograph. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a4e581632977d21a2a470e793323b048
https://pubmed.ncbi.nlm.nih.gov/6261137
https://pubmed.ncbi.nlm.nih.gov/6261137
Autor:
D N, Benslay, R, Nickander
Publikováno v:
European journal of rheumatology and inflammation. 5(2)
The ability of benoxaprofen to suppress bone damage associated with adjuvant-induced arthritis in rats was studied radiographically over a 49-day period. Benoxaprofen was administered orally at a daily dose of 30 mg/kg. Treated and control groups of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ce83bc7b456c212e835cc585652854d
https://pubmed.ncbi.nlm.nih.gov/7084279
https://pubmed.ncbi.nlm.nih.gov/7084279
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 200(1)
alpha-d-Propoxyphene and its principle metabolite, alpha-d-norpropoxyphene, were compared pharmacologically to establish their relative opioid profiles as defined by naloxone reversal. Propoxyphene exhibited opioid activity in the following tests: mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::864dc00769bd71798c589f363eb7d222
https://pubmed.ncbi.nlm.nih.gov/13200
https://pubmed.ncbi.nlm.nih.gov/13200
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.